Fundai

Sobhan Pharmaceutical Group (DSOBHA) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DSOBHA
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations381,8041,970,3021,562,1621,734,537723,4541,035,194
Net cash inflow (outflow) from operating activities381,8041,970,3021,562,1621,734,537723,4541,035,194
Cash receipts from sale of property, plant and equipment784,4221,103,323683,3401,238,71795,513323,973
Cash payments for purchase of property, plant and equipment-1,662,138-2,071,950-497,392-1,325,5580-563,776
Cash payments for purchase of intangible assets-360000-390-131
Net cash inflow (outflow) from investing activities-878,076---161,84195,123-189,934
Net cash inflow (outflow) before financing activities-496,2721,001,6752,448,110175-7,033232,854
Cash receipts from sale of treasury shares373,31439,0100---
Cash payments for purchase of treasury shares-303,510-96,239-27,5060-22,000-427,496
Cash payments for principal of loans-857-704,843-1,825,534---
Cash payments for interest on loans-149,655-57,167-331,364---
Cash payments for dividends-237-300,141-1,264,613-1,572,521-825,610-612,406
Net cash inflow (outflow) from financing activities-80,945-989,380-2,449,0170-21,955-197,854
Net increase (decrease) in cash-577,21712,295-907175-28,98835,000
Cash balance at beginning of year585,96336,15014,51472,13299,876143,560
Cash balance at end of year8,74648,44513,60772,30770,888178,560
Non-cash transactions3,5213,704,3552,349226,5651,618,872590,332

Reporting periods

72 periods are on file for this report, from the period ending 1385/12/29 to the period ending 1405/06/31.